These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection. Fontenot D, Jones JK, Hossain MM, Nehete PN, Vela EM, Dwyer VA, Jagannadha Sastry K. Virology; 2007 Jun 20; 363(1):69-78. PubMed ID: 17320923 [Abstract] [Full Text] [Related]
24. Design, synthesis and evaluation of peptide libraries as potential anti-HIV compounds, via inhibition of gp120/cell membrane interactions, using the gp120/cd4/fab17 crystal structure. Boussard C, Doyle VE, Mahmood N, Klimkait T, Pritchard M, Gilbert IH. Eur J Med Chem; 2002 Nov 20; 37(11):883-90. PubMed ID: 12446047 [Abstract] [Full Text] [Related]
29. Novel therapies based on mechanisms of HIV-1 cell entry. Kilby JM, Eron JJ. N Engl J Med; 2003 May 29; 348(22):2228-38. PubMed ID: 12773651 [No Abstract] [Full Text] [Related]
30. A high-throughput fluorescence polarization assay specific to the CD4 binding site of HIV-1 glycoproteins based on a fluorescein-labelled CD4 mimic. Stricher F, Martin L, Barthe P, Pogenberg V, Mechulam A, Menez A, Roumestand C, Veas F, Royer C, Vita C. Biochem J; 2005 Aug 15; 390(Pt 1):29-39. PubMed ID: 15836438 [Abstract] [Full Text] [Related]
31. Protein minimization of the gp120 binding region of human CD4. Sharma D, Balamurali MM, Chakraborty K, Kumaran S, Jeganathan S, Rashid U, Ingallinella P, Varadarajan R. Biochemistry; 2005 Dec 13; 44(49):16192-202. PubMed ID: 16331979 [Abstract] [Full Text] [Related]
32. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents. Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H. Bioorg Med Chem; 2013 May 01; 21(9):2518-26. PubMed ID: 23535561 [Abstract] [Full Text] [Related]
37. Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs. Kuwasaki T, Hatta M, Takeuchi H, Takaku H. J Antimicrob Chemother; 2003 Apr 01; 51(4):813-9. PubMed ID: 12654739 [Abstract] [Full Text] [Related]
39. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens. Franke R, Hirsch T, Overwin H, Eichler J. Angew Chem Int Ed Engl; 2007 Apr 01; 46(8):1253-5. PubMed ID: 17211914 [No Abstract] [Full Text] [Related]
40. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors. Tiberi M, Tintori C, Ceresola ER, Fazi R, Zamperini C, Calandro P, Franchi L, Selvaraj M, Botta L, Sampaolo M, Saita D, Ferrarese R, Clementi M, Canducci F, Botta M. Antimicrob Agents Chemother; 2014 Jun 01; 58(6):3043-52. PubMed ID: 24614386 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]